Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion description "[Riboflavin is considered to be effective by activating the NADPH diaphorase (NADPH flavin reductase) system and appears to be useful for the treatment of congenital methaemoglobinaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion evidence source_evidence_literature NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion SIO_000772 6893937 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion wasDerivedFrom befree-20150227 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion wasGeneratedBy ECO_0000203 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.